From our founding in 2006, KemPharm® has been and continues to be a prodrug discovery company focused on building a portfolio of prodrugs that represent an improvement over currently approved drugs and address unmet medical needs in large, established markets.
Our LAT™ prodrug discovery technology seeks to improve the properties of existing drugs by identifying pharmaceuticals that address a large patient population wher...
From our founding in 2006, KemPharm® has been and continues to be a prodrug discovery company focused on building a portfolio of prodrugs that represent an improvement over currently approved drugs and address unmet medical needs in large, established markets.
Our LAT™ prodrug discovery technology seeks to improve the properties of existing drugs by identifying pharmaceuticals that address a large patient population where conversion to a prodrug could enable better treatment outcomes, alleviate unwanted or unintended side-effects or enhance the marketability of the drug.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.